These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 20233654)

  • 21. Syringe exchange programs --- United States, 2008.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2010 Nov; 59(45):1488-91. PubMed ID: 21085091
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Syringe use and reuse: effects of syringe exchange programs in four cities.
    Heimer R; Khoshnood K; Bigg D; Guydish J; Junge B
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998; 18 Suppl 1():S37-44. PubMed ID: 9663622
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structural impediments to operational syringe-exchange programs.
    Heimer R; Bluthenthal RN; Singer M; Khoshnood K
    AIDS Public Policy J; 1996; 11(4):169-84. PubMed ID: 10915251
    [No Abstract]   [Full Text] [Related]  

  • 24. The effectiveness and safety of syringe vending machines as a component of needle syringe programmes in community settings.
    Islam M; Wodak A; Conigrave KM
    Int J Drug Policy; 2008 Dec; 19(6):436-41. PubMed ID: 17766100
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Update: syringe exchange programs--United States, 2002.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2005 Jul; 54(27):673-6. PubMed ID: 16015218
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of increased legal access to needles and syringes on community pharmacies' needle and syringe sales--Connecticut, 1992-1993.
    Valleroy LA; Weinstein B; Jones TS; Groseclose SL; Rolfs RT; Kassler WJ
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Sep; 10(1):73-81. PubMed ID: 7648288
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Needle and syringe sharing practices among injecting drug users in Tehran: a comparison of two neighborhoods, one with and one without a needle and syringe program.
    Zamani S; Vazirian M; Nassirimanesh B; Razzaghi EM; Ono-Kihara M; Mortazavi Ravari S; Gouya MM; Kihara M
    AIDS Behav; 2010 Aug; 14(4):885-90. PubMed ID: 18483849
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Exploring stakeholder perceptions of acceptability and feasibility of needle exchange programmes, syringe vending machines and safer injection facilities in Tijuana, Mexico.
    Philbin MM; Mantsios A; Lozada R; Case P; Pollini RA; Alvelais J; Latkin CA; Magis-Rodriguez C; Strathdee SA
    Int J Drug Policy; 2009 Jul; 20(4):329-35. PubMed ID: 18963906
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Harm Reduction Coalition.
    Clear A; Springer E; Lanier C
    Newsline People AIDS Coalit N Y; 1998 Jun; ():27-34. PubMed ID: 11367469
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Needle sharing and participation in the Amsterdam Syringe Exchange program among HIV-seronegative injecting drug users.
    Hartgers C; van Ameijden EJ; van den Hoek JA; Coutinho RA
    Public Health Rep; 1992; 107(6):675-81. PubMed ID: 1454980
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Public opinion on needle and syringe programmes: avoiding assumptions for policy and practice.
    Treloar C; Fraser S
    Drug Alcohol Rev; 2007 Jul; 26(4):355-61. PubMed ID: 17564870
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prescribing syringes to injection drug users: what the family physician should know.
    Rich JD; Taylor L; Mehrotra M; Mason R; Stozek M; Stancliff S
    Am Fam Physician; 2003 Jul; 68(1):45-7. PubMed ID: 12887113
    [No Abstract]   [Full Text] [Related]  

  • 33. What's community got to do with it? Implementation models of syringe exchange programs.
    Downing M; Riess TH; Vernon K; Mulia N; Hollinquest M; McKnight C; Jarlais DC; Edlin BR
    AIDS Educ Prev; 2005 Feb; 17(1):68-78. PubMed ID: 15843111
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Strategies to optimize the impact of needle exchange programs.
    Rich JD; Strong LL; Mehrotra M; Macalino G
    AIDS Read; 2000 Jul; 10(7):421-9. PubMed ID: 10932846
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The law (and politics) of safe injection facilities in the United States.
    Beletsky L; Davis CS; Anderson E; Burris S
    Am J Public Health; 2008 Feb; 98(2):231-7. PubMed ID: 18172151
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Geographic approaches to quantifying the risk environment: drug-related law enforcement and access to syringe exchange programmes.
    Cooper HL; Bossak B; Tempalski B; Des Jarlais DC; Friedman SR
    Int J Drug Policy; 2009 May; 20(3):217-26. PubMed ID: 18963907
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Social and political factors predicting the presence of syringe exchange programs in 96 US metropolitan areas.
    Tempalski B; Flom PL; Friedman SR; Des Jarlais DC; Friedman JJ; McKnight C; Friedman R
    Am J Public Health; 2007 Mar; 97(3):437-47. PubMed ID: 17267732
    [TBL] [Abstract][Full Text] [Related]  

  • 38. NIMBY localism and national inequitable exclusion alliances: The case of syringe exchange programs in the United States.
    Tempalski B; Friedman R; Keem M; Cooper H; Friedman SR
    Geoforum; 2007 Nov; 38(6):1250-1263. PubMed ID: 18978931
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Is Law Enforcement Support the Missing Key to Thriving Syringe Service Programs in US Rural Areas?
    Davis SM; Kristjansson AL
    Am J Public Health; 2024 May; 114(5):458-460. PubMed ID: 38598762
    [No Abstract]   [Full Text] [Related]  

  • 40. From ideology to logistics: the organizational aspects of syringe exchange in a period of institutional consolidation.
    Henman AR; Paone D; Des Jarlais DC; Kochems LM; Friedman SR
    Subst Use Misuse; 1998 Apr; 33(5):1213-30. PubMed ID: 9596384
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.